DEUTSCHE BANK AG\
BankPosition in FHTX — Foghorn Therapeutics Inc.
CIK 948046
FRANKFURT AM MAIN, 2M
Position in FHTX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$178,300
+$47,229 QoQ
Shares Held
36,537
+33.2% QoQ
Ownership
0.062%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 102 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 3%
Shared 0%
None 97%
Common Shares in FHTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $3,190,028,280 across 296 Biotechnology names. FHTX ranks #251 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,579,110 | $784,391,303 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
518,409 | $323,248,743 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
815,400 | $245,459,858 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
888,019 | $166,308,196 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,717,951 | $152,395,510 | |
| 6 | INCY |
Incyte Corp
|
1,262,988 | $143,172,312 | |
| 7 | ARGX |
Argenx SE
|
137,335 | $127,415,291 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
249,611 | $78,899,539 |
All Filings in FHTX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $178,300 | 36,537 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $131,071 | 27,421 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $148,072 | 27,421 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $124,987 | 25,560 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $98,182 | 20,890 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $76,248 | 20,890 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $58,102 | 12,310 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $114,605 | 12,310 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $45,079 | 7,840 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $64,375 | 9,594 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $64,454 | 9,993 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $49,965 | 9,993 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $70,350 | 9,993 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $80,469 | 12,979 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $55,115 | 8,639 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $72,955 | 8,503 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $133,932 | 9,848 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $161,849 | 10,627 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $271,809 | 11,885 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $1,322,514 | 94,940 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $2,017,793 | 189,109 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $2,938,006 | 222,914 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $102,282 | 5,046 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||